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Background: Insulin receptor (InsR) and insulin signaling proteins are widely distributed throughout the kidney
cortex. Insulin signaling can act in the kidney in multiple ways, some of which may be totally independent of its
primary role of the maintenance of whole-body glucose homeostasis. However, descriptions of the insulin signaling
in renal glomerular mesangial cells (MCs) are quite limited and the roles of insulin signaling in MC functions have
not been sufficiently elucidated.
Results: InsR silencing induced a unique phenotype of reduced fibronectin (FN) accumulation in renal glomerular
MCs. Transcription level of FN was not significantly changed in the InsR silenced cells, suggesting the phenotype
switching was caused by post-transcriptional modification. The decreased expression of InsR was associated with
enhanced activity of insulin-like growth factor-1 receptor (IGF-1R)/PI3K/Akt signaling pathway which contributed in
part to the attenuation of cellular FN accumulation. Formation of IGF-1R homodimer was increased in the InsR
silenced cells. The InsR silenced cells also showed increased sensitivity to exogenous IGF-1, and increased PI3K
activity was reversed significantly by incubating cells with IGF-1R specific antagonist, AG538. PI3K/Akt dependent
activation of cAMP responsive element-binding protein (CREB)-1 induced expression of matrix metalloproteinase
(MMP)-9 and suppressing MMP activity by doxycycline partially reversed FN accumulation in the InsR silenced cells.
Conclusions: The effects of InsR silencing on cellular FN accumulation in vitro are, at least partially, mediated by
increased degradation of FN by MMPs which is induced by enhanced signaling sequence of IGF-1R/PI3K/Akt/
CREB-1.
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One of the common local pathologic changes of glomer-
ulonephropathy is accumulation of extracellular matrix
(ECM) components, including fibronectin (FN), which
results in glomerulosclerosis. Although the mechanisms
responsible for the ECM protein deposition are still in-
conclusive, the role of renal glomerular mesangial cells
(MCs) in this sclerotic change has been gathering in-
creasing attentions. Glomerular mesangium is an area
which shows the most prominent ECM accumulations in* Correspondence: nyano@wihri.org; ytseng@wihri.org
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reproduction in any medium, provided the ordiseased kidney. And the resulting glomerular fibrosis
has been recognized as the major degenerative event in
glomerulonephropathies regardless of their etiologies
[1-3]. MCs are specialized pericytes located among the
mesangium area within the renal corpuscle of the kidney
[4]. ECM protein deposition could be caused by matrix
deposition exceeding matrix degradation. Many studies
have focused on a possible imbalance of in situ synthesis
and degradation of ECM proteins in glomeruli [5,6].
Indeed, some animal experiments have shown that the
accumulation of ECM proteins in focal segmental glo-
merulosclerosis is associated with increased ECM protein
synthesis coupled with suppression of expression or ac-
tivity of proteolytic enzymes, including cathepsins andd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Stable transfection of shRNA against InsR in MES-13
mesangial cells. Cells (90% confluent) were stably transfected as
described and serum-deprived for 16 hours. Immunoblotting with
anti-InsRα antibody was performed on three clones of InsR silenced
cells (clone 7, 11, 13) along with scrambled oligo (SC) transfected
cells. An image of gel stained after transfer was shown as a loading
monitor (middle panel). InsR expression levels were evaluated by
densitometric analysis. Data are means ± SEM from four
independent experiments. *, P<0.01 versus SC transfected cells, WT,
wild type.
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secrete MMPs that degrade intact glomerular basement
membrane, gelatin, soluble type IV collagen and FN at
neutral pH [5,9]. MMPs and their specific inhibitors,
tissue inhibitor of metalloproteinases (TIMPs), play an
important role in regulating glomerular matrix remodeling
[5,9,10]. Based on these findings, besides their three pri-
mary functions, that is, filtration, structural support, and
phagocytosis, MCs have been postulated to be a key
player for FN regulation in the kidney and is speculated
as one of the major contributors to the sclerotic lesion in
glomeruli [11].
The insulin receptor (InsR) and insulin signaling pro-
teins are widely distributed throughout kidney cortex
[12,13]. Insulin signaling can act in the kidney in multiple
ways, some of which may be totally independent of its
primary role of the maintenance of whole-body glucose
homeostasis. As for renal tissue, the roles for insulin sig-
naling in tubular epithelial cells have been described
extensively in previous studies. The signaling is clearly
anti-natriuretic, affecting sodium reabsorption in the
proximal tubule [14], thick ascending limb [15,16], and
collecting duct [17]. In contrast, descriptions of insulin
signaling in MCs are limited and the roles of insulin
signaling in MC functions have not been sufficiently
elucidated.
The InsR and IGF-1R are structurally related trans-
membrane glycoproteins with approximately 50% amino
acid sequence identity [18]. Post-translational processing
results in dimerization and disulphide linkage of prore-
ceptors. This is followed by proteolytic cleavage, which
generates α and β subunits [19]. Mature and functional
receptors thus have the subunit composition of (αβ)2.
The extracellular α subunit contains a ligand binding site
and the transmembrane β subunit possesses tyrosine
kinase activity. The distinct physiological functions of in-
sulin and IGFs depend on differences in the distribution
and/or signaling potential of their respective receptors.
Despite of this, it has been shown that a proportion of
InsR and IGF-1R assemble as hybrid structures contain-
ing an (αβ) half of the InsR disulphide-linked to an (α’β’)
half of the IGF-1R [20-22]. These hybrid receptors are
functional, in that they bind IGF-1 with high affinity and
insulin with somewhat lower affinity [23,24], and display
IGF-1-induced autophosphorylation both in vitro and
in situ [24,25]. MCs express both InsR and IGF-1R
[11,26] and therefore have the potential to form func-
tional hybrid receptors. However, the significance of
hybrid receptors in MCs remains unclear.
Here, we explore the roles of InsR/IGF-1R signaling in
cellular FN accumulation, using a SV40 immortalized
mouse mesangial cell line, MES-13. With silencing InsR
expression by shRNA, the cells showed significant re-
duction of cellular FN accumulation. The aim of thepresent work was to identify responsible alterations of
the signaling pathway for the phenotype switching. We
provide evidences that rearrangement in the balance
between insulin and IGF-1 receptor homodimers and
hybrid receptors contributed to the phenotype switching.
We also demonstrate cAMP responsive element-binding
protein (CREB-1) and MMP-9 as downstream factors for
the attenuation of cellular FN accumulation.Results
InsR silencing in MES-13 cells
Twenty clones of shRNA against InsR transfected cells
were tested for their phenotypes. Cells were seeded in
2 × 105/ml density. The next day, serum was deprived
from the medium for 16 hours. The quiescent cells were
harvested and lysates were subject to Western blotting
for InsRα. Three clones (#7, 11 and 13) which showed
more than 85% suppression of InsR expressions were
employed in the experiments (Figure 1).
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silenced cells
Cell lysates from InsR silenced or scrambled oligo
plasmid (SC) transfected cells were harvested as described
above, and then served for Western blotting or semi-
quantitative RT-PCR for FN. The InsR silenced cells
showed remarkably decreased cellular FN accumulation,
but no changes in transcriptional level of FN (Figure 2A,
B). This finding suggested that the attenuation of cellular
FN accumulation in InsR silenced cell is due to post-
transcriptional modification.Activation of PI3K/Akt pathway and suppression of
Ras/Erk1/2 in the InsR silenced cells
The cell lysates were subject to in vitro lipid kinase assay
for measurement of PI3K activity. InsR silencing induced
a significant increase in PI3K activity (Figure 3A). Phos-
phorylation of Akt and p70S6 kinase (p70S6K), two
important downstream signaling factors, was also sig-
nificantly increased indicating a general enhancement
of PI3K/Akt signaling pathway in InsR silenced cells
(Figure 3B). These results were confirmed by measure-
ment of Akt activity (Figure 3C). Cell lysates were also
subject to Ras pull-down assay and Western blotting
for Erk1/2. InsR silencing induced significant decreases
in Ras activity and phosphorylation of Erk1/2, indicat-
ing a suppression of Ras/Erk1/2 (Figure 3D,E).Attenuation of FN accumulation depends on PI3K/Akt
signaling in the InsR silenced cells
In order to clarify how alteration in PI3K/Akt and Ras/
Erk1/2 signaling pathways contributed to attenuation ofFigure 2 Silencing of InsR attenuated cellular accumulation of FN in M
was performed on clones of InsR silenced cells and SC transfected cells. An
(middle panel). Cellular FN levels were evaluated by densitometric analysis.
versus SC transfected cells (lower panel). (B) Semi-quantitative analysis of F
RNA isolated from quiescent cells was subject to RT–PCR using FN and GA
amplification cycles. One representative image from four independent exp
by densitometric analysis. Data are means ± SEM from four independent ecellular FN accumulation, we co-transfected a dominant
negative (DN)-Akt or a constitutively activated H-Ras
cDNA to the InsR silenced cells. Lysates from these cells
were subject to Western blotting with anti-FN antibody
to determine the effects of suppression of PI3K/Akt or
enhancement of Ras/Erk1/2 on FN accumulation. As
expected, silencing of InsR resulted in a significant re-
duction in the cellular levels of FN. The reduction,
however, were partially reversed by co-transfection of a
DN-Akt cDNA. In contrast, co-transfection of a consti-
tutively activated-H-Ras cDNA did not influence InsR
silencing induced reduction in FN levels (Figure 4).
These finding suggest InsR silencing induced attenu-
ation in FN is partially dependent on PI3K/Akt but not
on Ras/Erk1/2 pathway.
PI3K/Akt activation depends on IGF-1R signaling in the
InsR silenced cells
As mentioned above, MCs express both InsR and
IGF-1R. In order to investigate the involvement of
IGF-1R in the augmented PI3K/Akt signaling pathway
in the InsR silenced cells, we performed the following
two experiments. First, the cells were incubated with
vehicle (DMSO) or an IGF-1R specific antagonist, AG538
(50μM) for 12 hours, and the cell lysates were subject to
in vitro immunoprecipitation lipid kinase assay to mea-
sure PI3K activity. Pharmacological blockade of IGF-1R
effectively reversed the effect of InsR silencing on redu-
cing PI3K activity (Figure 5A). The finding suggests that
the elevated PI3K activity in InsR silenced cells was
mediated by IGF-1R.
Next, we investigated sensitivity of the cells to exogen-
ous IGF-1. The cells were stimulated with vehicle (H2O)ES-13 mesangial cells. (A) Immunoblotting with anti-FN antibody
image of gel stained after transfer was shown as a loading monitor
Data are means ± SEM from four independent experiments. *, P<0.01
N mRNA levels in InsR silenced and SC transfected MES-13 cells. Total
PDH (internal control) specific primers with the indicated number of
eriments is shown (upper panel). FN transcription levels were evaluated
xperiments.
Figure 3 Silencing of InsR enhanced PIK3/Akt signaling while suppressing Ras/Erk1/2 activities in MES-13 mesangial cells. (A) Cell
lysates were immunoprecipitated with an antibody againts phosphorylated-tyrosine, and PI3K activity was determined with in vitro lipid kinase
assay. PIP, Phosphoinositide 3-phosphate, the phosphorylated end product. Ori, origin of migration in thin-layer chromatography (upper panel).
The bar graph shows the densitometric scanning results (means ± SEM) from four independent experiments (lower panel). (B) Cell lysates were
subject to Western blotting with antibodies against phosphorylated-Akt (P-Akt, Thr308), total-Akt (T-Akt), phosphorylated-p70S6K (P-p70S6K) and
total-p70S6K (T-p70S6K). The bar graphs show the densitometric scanning results (means ± SEM) from four independent experiments. (C) Lysates
were immunoprecipitated with an immobilized anti-phospho-Akt (Ser473) antibody, and the kinase reaction was carried out in the presence of
cold ATP and GSK-3α/β fusion protein as described. An image of gel stained after transfer was shown as a loading monitor (middle panel). The
bar graph shows the densitometric scanning results (means ± SEM) from four independent experiments. (D) Ras activation was evaluated by
pulling down active GTP-loaded Ras with a GST fusion protein containing the Ras binding domain of Raf-1 (GST-Raf1-RBD) followed by blotting
with an anti-Ras antibody (upper panel). The bar graph shows the densitometric scanning results (means ± SEM) from four independent
experiments. (E) Cell lysates were subject to Western blotting with antibodies against phosphorylated-Erk1/2 (P-Erk1/2) and total Erk1/2 (T-Erk1/2).
The bar graph shows the densitometric scanning results (means ± SEM) from four independent experiments. *, P<0.05 vs. SC transfected cells.
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and the cell lysates were subject to in vitro immuno-
precipitation lipid kinase assay to measure PI3K activity.
The ratio of PI3K activity in rIGF-1 treated cells and
vehicle treated cells were used as an indicator for cell
sensitivity to IGF-1. In SC transfected cell, PI3K activitywas significantly increased by rIGF-1 pretreatment
(lanes 1, 3, Figure 5B). In InsR silenced cells, however,
the increase in PI3K activity in response to rIGF-1 was
even more significant (lanes 2, 4, Figure 5B). These
results suggest an increase in sensitivity to IGF-1 in
InsR silenced cells.
Figure 4 InsR silencing induced reduction in cellular
accumulation of FN was partially dependent on PI3K/Akt. Cells
were transfected with SC, sh-InsR, sh-InsR + dominant negative Akt
(DN-Akt) cDNA or sh-InsR + activated H-Ras (aH-Ras) cDNA. Cell
lysates were subject to Western blotting with an anti-FN antibody. A
gel stained after transfer was shown as a loading monitor. The bar
graph shows the densitometric scanning result (means ± SEM) from
four independent experiments. *, P<0.01, NS, no significant
difference.
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formation
InsR and IGF-1R are known to be originated from a
common ancestral gene and sharing structures which are
similar enough to form a hybrid receptor. To determine
whether or not formation of hybrid receptors play a role
in the observed activation of IGF-1R/PI3K/Akt signaling
pathway in the InsR silenced cells, two set of experiments
were performed. First, co-immunoprecipitation experi-
ments were carried out in wild type (non-transfected)
MES-13 cells. The results verified that IGF-1R and InsR
can be reciprocally co-immunoprecipitated (Figure 6A).
This confirmed specific detection of hybrid receptors,
which form via random dimerization as a function of
the molar fractions of the IGF-1R and InsR [21,27,28].
Suppressed expression of InsR would therefore be
expected to affect the balance between formation of
hybrid receptors and homodimers. Next, lysates from
the SC transfected cells and InsR silenced cells were
immunoprecipitated with anti-InsRα or anti-IGF-1Rαantibody followed by immunoblotting with anti-IGF-1Rβ
for co-immunoprecipitation of hybrid receptors. Sup-
pression of InsR resulted in 1) decreased IGF-1R co-
precipitation, consistent with reduction in hybrid receptor
formation (lanes 1–2, upper panel, Figure 6B); 2) increased
formation of IGF-1R homodimers (lane 3–4, upper panel,
Figure 6B). The latter was confirmed by immunoblotting
the supernatants with anti-IGF-1Rβ. Detection of IGF-1R
was significantly increased in the anti-InsRα immuno-
precipitated supernatant from InsR silenced cells, indicat-
ing increased formation of IGF-1R homodimers (middle
panel, Figure 6B). Taken together, InsR silencing resulted
in reduced formation in IGF-1R/InsR hybrid receptor but
increased formation of IGF-1R homodimer in MES-13
cells. These alterations in the balance of InsR and IGF-1R
homodimer and hybrid receptor might contribute to
the observed changes in signaling pathways in the InsR
silenced cells.
CREB-1-mediated MMP-9 expression leads to increased
degradation of cellular FN in the InsR silenced cells
In the process for exploring the downstream factors
which are involved in altered FN accumulation, a couple
of unique phenotypes in InsR silenced cells were indenti-
fied. First, phosphorylation of CREB-1 is enhanced in the
InsR silenced cells (Figure 7A). The elevated phosphoryl-
ation was effectively reversed by shutting down Akt
activity by transfecting a dominant negative (DN)-Akt
cDNA (Figure 7B). Second, expression of MMP-9 was
increased in InsR silenced cells, and the increased ex-
pression was partially dependent on Akt or CREB-1
activity (Figure 7C).
Next, we incubated cells with doxycycline (10μg/mL),
a broad-spectrum MMP inhibitor, for 72 hours, and
then evaluated intracellular FN by Western blotting.
As expected cellular accumulation of FN in InsR silenced
cells was about 20% of that of SC transfected cells. Inhib-
ition of MMP with doxycycline in InsR silenced cells
effectively reversed the reduction in intracellular FN
levels to about 70% of that of SC cells (Figure 6D).
Taken together, these findings suggest that the attenuated
cellular accumulation of FN in the InsR silenced cells
was partially dependent on increased degradation by
MMP which was induced by IGF-1R/PI3K/Akt/CREB-1
signaling pathways.
Discussion
In cells expressing both InsR and IGF-1R, InsR hemire-
ceptors may heterodimerize with IGF-1R hemireceptors,
leading to the formation of hybrid receptors (HRs).
Heterodimerization of the two receptors is due to the
high degree of homology between InsR and IGF-1R,
which ranges from 27 to 84% depending on the region
that is compared [27,29]. Heterodimerization is believed
Figure 5 PI3K activation in InsR silenced cells was dependent on IGF-1R signaling. (A) Cells were incubated with AG538, an IGF-1R specific
antagonist, or vehicle (DMSO) for 12 hours, and the cell lysates were subject to in vitro lipid kinase assay. PIP (phosphoinositide 3-phosphate), the
phosphorylated end product. Ori, origin of migration in TLC. The bar graph shows the densitometric scanning results (means ± SEM) from four
independent experiments. *, P<0.01 vs. SC transfected cells. (B) Cells were treated with vehicle (H2O) or recombinant IGF-1 (rIGF-1, 10ng/mL) for
5 minutes, and the cell lysates were subject to in vitro lipid kinase assay (upper panel). Cell sensitivity to extrinsic IGF-1 is expressed as the ratio of
PI3K activity in IGF-1 treated cells to that of vehicle treated cells. Data are means ± SEM from four independent experiments. *, P<0.05 vs. SC
transfected cells.
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So the cellular proportions of homodimers and hybrids
are supposed to be dependent on the expression ratios of
each hemidimers [21-24,28,30]. Although, the physio-
logical role of HRs is still unclear, early studies carried
out with affinity chromatography-purified HRs indicated
that these receptors mostly bind IGF-1 and that they
bind insulin with much lower affinity [24,31].
Findings in the present study suggested that silencing
InsR caused increased formation of IGF-1R homodimers
in MCs. It’s possible that the change in the balance of the
homodimers and hybrid receptors induced remarkable
phenotypic changes of the attenuated cellular FN accu-
mulation. Regardless of etiology, most end-stage glom-
erular diseases are characterized by accumulation of
ECM proteins, including FN, in mesangium and other
areas in glomeruli [1-3]. Over accumulation of the ECMs
leads to sclerotic non-functional status of the kidney.
So controlling the local ECM accumulation is believed
to be one of the key therapeutic targets to prevent the
development and progression of glomerular diseases. In
spite of the extensive studies in the last decades, the
mechanisms underlying this abnormal accumulation of
ECM have not been fully elucidated. Our in vitro data
suggested that alteration in the balance between InsRand IGF-1R and the resultant changes in PI3K/Akt sig-
naling pathway contributed to the attenuation of cellu-
lar FN accumulation in MCs.
Expression of InsR is influenced by multiple factors.
Estrogen showed inhibitory effect on Ir promoter activity
[32]. In accordance with the negative effect of the estro-
gen, monocyte InsR content is higher during the luteal
phases in adult females. This elevation is abolished by
use of oral contraceptives or pregnancy [33]. Moreover,
glucocorticoids and thyrotropin have been reported to
enhance InsR expression while insulin down-regulates
its cognate ligand [34-37]. Finally, nutrition and exercise
have been reported to influence IR expression [38].
Various chronic glomerulopathy prone conditions such as
poorly controlled diabetes, malignant tumors, systemic
autoimmune diseases, pregnancy are inclinable to be ac-
companied endocrinological/metabolic disturbance which
may affect expression of InsR or IGF-1R [39-42]. In these
patients, appropriate control of the metabolic disturbance
may potentially contribute to prevent the renal complica-
tions by correcting the InsR/IGF-1R balances.
IGF-1 has been shown to regulate protein synthesis in
renal proximal tubular epithelial cells by activating both
PI3K and Erk pathways [43]. Whereas, in the present
study, InsR silencing caused increased PI3K activity and
Figure 6 Silencing of InsR disrupted InsR/IGF-1R hybrid
receptor formation and increased IGF-1R homodimer
formation. (A) Lysates from non-transfected MES-13 mesangial cells
were immunoprecipitaed (IP) using antibodies against IGF-1Rα, InsRα
or control (CTR) IgG, an irrelevant control antibody.
Immunoprecipitates were immuneblotted (IB) for IGF-1Rβ or InsRβ.
WCL, whole cell lysate. An image of gel stained after transfer was
shown as a loading monitor (lower panel). (B) Hybrid receptors in SC
or InsR shRNA (sh-InsR) transfected cells were detected by
immunoprecipitation with antibodies directed against either the
InsRα or IGF-1Rα. Immunoprecipitated receptors were detected by
immunoblotting with an anti-IGF-1Rβ antibody (upper panel). An
image of gel stained after transfer was shown as a loading monitor.
Immunodepletion was assessed by immunoblotting the
supernatants from immunoprecipitate with an anti-IGF-1Rβ antibody
(middle panel). The bar graph shows the densitometric scanning
results (upper panel, means ± SEM) of four independents
experiments *, P<0.05.
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discrepant findings has not been fully investigated but
can be explained for the following: 1) we used renal
glomerular MCs, which are specialized pericytes, whereas
others used renal proximal tubular epithelial cells; 2) In
our model, we showed silencing of InsR is associated
with reduced Erk1/2 and increased PI3K activity. The
latter can be blocked with IGF-1R inhibition. Hence, our
experimental model is different from others that reported
acute treatment with IGF-1 activates both PI3K and
Erk1/2; 3) Altered InsR/IGF-1R balance may also be a
factor for this characteristic phenotype of the InsR
silenced MCs. Elucidating further details in the mech-
anisms will benefit understanding significance of InsR/
IGF-1R balance in the fibrotie phenotype switching in
MCs.
The ECM accumulation can result from either
increased synthesis or decreased degradation of ECM
components or both. MMPs are one of the main contri-
butors to degrade ECMs. Quite a few numbers of
mechanisms for regulation of MMP activities and expres-
sions in various tissues have been reported and our study
is the first to describe the involvement of InsR/IGF-1R
signaling in MMP expression. We also showed CREB-1
as a specific transcription factor to regulate MMP ex-
pression in our model. Based on these findings, we pro-
posed a novel signaling model for regulation of cellular
FN accumulation. In this model, silencing InsR promotes
increased formation of IGF-1R homodimer which alters
the activation status of downstream kinases. Enhanced
activity of PI3K/Akt induces activation of CREB-1 and
results in increased MMP expression to promote FN
degradation. Since the MES-13 cells synthesize IGF-1
(Additional file 1) and since sensitivity to IGF-1 is
increase in the InsR silenced MCs, in our in vitro model
these endogenously produced IGF-1 possibly contributes
Figure 7 Increased MMP-9 expression and CREB-1 phosphorylation in InsR silenced cells. (A) Cell lysates from SC- and sh-InsR-transfected
cells were subject to Western blotting using an antibody against phosphorylated (P-CREB-1) or total CREB-1 (T-CREB-1). The bar graph shows
the densitometric scanning results (means ± SEM) from four independent experiments. *, P<0.01 vs. SC transfected cells. (B) Scrambled oligo
(SC)- and sh-InsR-transfected cells were co-transfected with pUSEamp(+) empty vector or a dominant negative (DN)-Akt vector. Cell lysates were
subject to Western blotting for CREB-1 as described in (A). The bar graph shows the densitometric scanning results (means ± SEM) from four
independent experiments. *, P<0.01(lower panel). (C) Cells were stably co-transfected with plasmids as indicated and lysates were subject for
Western blotting for MMP-9. pRS, a control plasmid for InsR shRNA; pUSE, pUSEamp(+), a control plasmid for DN-Akt; pGeneClip, a control plasmid
for CREB-1 shRNA (upper panel). An image of gel stained after transfer was shown as a loading monitor (middle panel). The bar graph shows the
densitometric scanning results (means ± SEM) from four independent experiments. *, P<0.01. (D) Scrambled oligo (SC)- and sh-InsR-transfected
cells were incubated with doxycycline (10μg/mL, 72 hours) and cell lysates were subject to Western blotting for FN. An image of gel stained after
transfer was shown as a loading monitor (middle panel). The bar graph shows the densitometric scanning results (sh-InsR/SC, means ± SEM) from
four independents experiments. *, P<0.01.
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autocrine manner.
Conclusions
In summary, we have identified the phenotype of
reduced cellular accumulation of FN in InsR silenced
MCs. We explored the mechanisms underlying this
unique phenotype. Our data suggest that the altered bal-
ance in the formation of InsR/IGF-1R homodimer and
hybrid receptor is a crucial factor in the phenotypeswitching in MCs. We also demonstrated that resultant
change in PI3K/Akt signaling pathway was involved in
the induction of this phenotype. We further established
that PI3K/Akt induced CREB-1 activation lead to
enhanced MMP-9 expression which was likely involved
in reduced FN accumulation by enhancing degradation
of FN. These findings provide important information for
largely unknown mechanisms in InsR/IGF-1R mediated
myofibroblast transdifferentiation (MFT) of MCs in glo-
merulopathies. Elucidating further details in this signaling
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glomerulosclerosis.Materials and methods
Cell culture
MES-13 mouse mesangial cells (ATCC #CRL-1927) were
grown in a 3:1 mixture of Dulbecco's modified Eagle's
and Ham's F-12 media (Invitrogen) supplemented with
5% (v/v) fetal bovine serum containing 50 units/ml
penicillin G and 50 μg/ml streptomycin in a humidified
atmosphere containing 5% CO2 at 37°C. Cells were first
grown up to 90% confluence and synchronized overnight
in serum-free medium prior to treatment. In some
experiments cells were treated with recombinant IGF-1
(Invitrogen) or AG538 (EMD Chemical), an IGF-1R se-
lective inhibitor, for the indicated durations.PI3K Assays
PI3K activity in cell lysate was determined with in vitro
mmunoprecipitation lipid kinase assay as described previ-
ously [44]. Briefly, cell lysates (0.5 mg) were immunopre-
cipitated with anti-phosphotyrosine (anti-pY) antibody
(Millipore), and L-α-phosphoinositide (Avanti Polar Lipids)
was used as the lipid substrate (2 μg/reaction). After
incubation, the final extracted reaction mixtures were
spotted onto silica gel-coated TLC plates (Whatman)
and run in TLC buffer (65% n-propanol, 0.54 M acetic
acid).Antibodies
Antibody against fibronectin was purchased from Milli-
pore. Antibodies against InsRα, InsRβ, IGF-1Rα and
phospholylated or total CREB-1 were purchased from
Santa Cruz Biotechnology. Antibodies against phos-
phorylated or total Akt, phosphorylated or total Erk1/2
and phosphorylated or total p70S6, IGF-1Rβ and MMP-9
were purchased from Cell Signaling Technology.Immunoprecipitation
For immunoprecipitation, protein lysates (0.5mg) were
incubated with an antibody specific for InsRα or IGF-
1Rα at 4°C for 4 hours with continuous rotation. After
the incubation, a 20-μl packed volume of protein G-
Sepharose (GE-Health Care) was added to the lysates
and incubated for another 4 hours at 4°C. After washing,
45 μl of 1× Laemmli sample buffer was added to the
beads. The sample was heated in boiling water for
5 minutes and quenched on ice for 2 minutes. After
vortex and centrifuge, 20 μl of the supernatant was
resolved on a 7.5% SDS-PAGE gel and immunoblotted
with appropriate antibody.Pull down assay for Ras activity
Cells were lysed in Mg2+ IP buffer (25mM HEPES,
pH7.7, 150mM NaCl, 1% Igepal CA-630, 10mM MgCl2,
1mM EDTA and 2% glycerol). Cleared cell lysates were
normalized with the BCA assay (Santa Cruz Biotech-
nology). Normalized cell lysates were incubated with
Raf-1 RBD preconjugated agarose (Millipore) for 2 hours
at 4°C. Pelleted agarose were washed three times with
IP buffer. Protein bound to the beads was eluted
with 1xLaemmli’s buffer and subject to 12% SDS-
polyacrylamide gel electrophoresis (SDS-PAGE). Ras was
detected with a specific monoclonal antibody (clone
Ras10, Millipore).
In vitro IP Akt activity assay
Cells were serum-starved for 16 hours, and then washed
twice with phosphate-buffered saline and lysed in ice-
cold lysis buffer (20mM Tris, pH 7.4, 150mM NaCl,
1% Triton X-100, 1mM EDTA, 1mM EGTA, 2.5mM
sodium pyrophosphate, 1mM β-glycerolphosphate, 1mM
sodium orthovanadate, 1μg/ml leupeptin, and 1mM phe-
nylmethylsulfonyl fluoride). The extracts were centrifuged
to remove cellular debris, and normalized by BCA assay
(Santa Cruz). 250μg of protein from the lysate samples
was incubated with gentle rocking at 4°C overnight with
immobilized anti-phospho-Akt (Ser473) antibody cross-
linked to sepharose beads (Cell Signaling Technology).
After phosphorylated Akt was selectively immunopreci-
pitated from the cell lysates, the immunoprecipitated
products were washed twice in lysis buffer and twice
in kinase assay buffer (25mM Tris, pH 7.5, 10mM
MgCl2, 50mM β-glycerolphosphate, 0.1mM sodium
orthovanadate, and 2mM dithiothreitol), and the sam-
ples were resuspended in 40μl of kinase assay buffer con-
taining 200μM ATP and 1μg of GSK-3α fusion protein.
The kinase reaction was allowed to proceed at 30°C for
30 minutes and stopped by the addition of Laemmli SDS
sample buffer. Reaction products were resolved by 15%
SDS-PAGE followed by Western blotting with an anti-
phospho-GSK-3α/β antibody (Cell Signaling Technology).
Stable transfection
A vector expressing shRNA against InsR was purchased
from Santa Cruz Biotechnology. A vector expressing
shRNA against CREB1 was purchased from SABioscience.
A vector expressing dominant negative Akt1 was engi-
neered by inserting a K179M mutant dominant negative
Akt1 cDNA (Millipore) into a multiple cloning site of
a eukaryotic expression vector, pUSEamp(+) (Millipore).
A 529F mutant constitutively activated H-Ras cDNA
(Millipore) was processed similarly to engineer a vector
expressing constitutively activated H-Ras. Stable trans-
fection of the constructs in MES-13 cells was performed
using Lipofectamine 2000 (Invitrogen) according to the
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http://www.biosignaling.com/content/10/1/29manufacturer's instructions. Individual single cells were
isolated and screened for neomycin or puromycin resist-
ance. Phenotypes of the transfected cells were examined
by Western blotting, IP Akt assay or Ras pull-down assay
(Figure 1, Additional files 2, 3, 4).RT-PCR
Total RNA was isolated from cells using TRIzol reagent
(Invitrogen). Reverse transcription was carried out on
total RNA using SuperScript III (Invitrogen) followed by
PCR using gene specific primers (Additional file 5).Statistical analysis
Statistical significance of the difference among groups
was analyzed by the paired Student’s t test or parametric
ANOVA and Ryan’s multiple comparison test using
Microsoft Exel (Microsoft) and ANOVA4 on the Web
(http://www.hju.ac.jp/~kiriki/anova4/). All data were
represented as the mean ± SEM of four different experi-
ments unless otherwise noted in the figure legends. A
probability of p<0.05 was considered to represent a sig-
nificant difference.Additional files
Additional file 1: MES-13 mesangial cells produce intrinsic IGF-1. (A)
Lysates from quiescent control (SC) and InsR silenced (sh-InsR) cells were
subject to immunoblotting with antibody against IGF-1. An image of gel
stained after transfer was shown as a loading monitor. (B) Total RNA
isolated from quiescent cells was subject to RT–PCR using IGF-1 and
GAPDH (internal control) specific primers.
Additional file 2: Phenotyping of activated H-Ras transfected cells.
(A) Ras activities of the InsR shRNA and activated H-Ras double
transfected cells were evaluated by Ras pull-down assay as described
under “Materials and methods”. Clones, #2, 4 and 8 were used for the
experiments. (B) Phosphorylation of Erk1/2 of the selected clones were
evaluated by Western blotting. P-Erk1/2, phosphorylated Erk1/2; T-Erk1/2,
total Erk1/2.
Additional file 3: Phenotyping of DN-Akt transfected cells. Akt
activities of InsR sh-RNA and DN-Akt double transfected cells were
evaluated by IP Akt activity assay as described under “Materials and
methods”. Clones #3 and 7 were used for the experiments.
Additional file 4: Phenotyping of CREB-1 shRNA transfected cells.
CREB-1 levels in InsR and CREB-1 shRNA double transfected cells were
evaluated by Western blotting. An image of gel stained after transfer was
shown as a loading monitor. Clones #1, 4 and 5 were used for the
experiments.
Additional file 5: PCR primer sequences for fibronectin, IGF-1 and
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